Immunogenicity and Safety of BPZE1 Intranasal Pertussis Vaccine in Healthy School-age Children

Clinical trial NCT05116241 · COMPLETED

Trial details

NCT number: NCT05116241
Sponsor: ILiAD Biotechnologies
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bordetella Pertussis, Whooping Cough

Start date: 2021-11-11
Primary completion: 2024-05-15
Enrollment: 368

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.